Keith James

Keith James's AcademicInfluence.com Rankings

Keith James

Philosophy

#8677

World Rank

#12101

Historical Rank

Logic

#5706

World Rank

#7127

Historical Rank

philosophy Degrees

Keith James

Biology

#11789

World Rank

#15213

Historical Rank

Immunology

#771

World Rank

#794

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Keith James's Degrees

Bachelors Biology University of California, Berkeley
Doctorate Medicine University of California, San Francisco
PhD Immunology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Keith James Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Keith James's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

BCG immunotherapy of bladder cancer: 20 years on (1999) (468)
Interactions between cytokines and α2-macroglobulin (1990) (242)
Human monoclonal antibody production. Current status and future prospects. (1987) (220)
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. (1992) (199)
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. (1983) (195)
Immunosuppression by seminal plasma and its possible clinical significance. (1984) (179)
Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy (1995) (161)
Extracellular organelles (prostasomes) are immunosuppressive components of human semen (1991) (152)
Immunosuppression by Human Seminal Plasma&—Extracellular Organelles (Prostasomes) Modulate Activity of Phagocytic Cells (1992) (145)
Lymphocyte sub-populations in the male genital tract. (1985) (129)
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. (1990) (117)
Immunocompetent cells in human testis in health and disease. (1987) (109)
Alpha2 macroglobulin and its possible importance in immune systems (1980) (99)
Intra-epithelial lymphocytes in the normal epididymis. A mechanism for tolerance to sperm auto-antigens? (1984) (99)
Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. (2000) (95)
HLA-DR expression by high grade superficial bladder cancer treated with BCG. (1989) (86)
Effect of Antilymphocytic Antibody and Antibody Fragments on Human Lymphocytes in vitro (1967) (84)
Role for CD40-CD40 ligand interactions in the immune response to solid tumours. (2000) (83)
Leucocytes in the ejaculate from fertile and infertile men. (1986) (83)
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. (1983) (76)
Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). (1967) (71)
Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. (1995) (71)
The Activation of Human Peripheral Lymphocytes by Products of Staphylococci (1965) (70)
Local immune responses after intravesical BCG treatment for carcinoma in situ. (1987) (65)
Immunosuppression by seminal prostaglandins. (1989) (63)
The role of hepatocyte growth factor and its receptor c‐met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs (2001) (62)
Seminal lymphocytes, plasma and AIDS (1984) (54)
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis. (1998) (53)
Molecular biology of human proteins/p=m-/with special reference to plasma proteins (1967) (53)
Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy. (1994) (50)
The quantitative estimation of α2-macroglobulin in normal, pathological and cord sera (1966) (49)
Characterization of Antilymphocytic Antibody (1967) (48)
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. (1975) (48)
Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma. (1976) (48)
Serum alpha 2-macroglobulin levels in diabetes. (1980) (47)
Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. (1981) (45)
Anti-lymphocytic antibody--a review. (1967) (45)
The inhibitory effects of interferon gamma on the growth of bladder cancer cells. (1992) (45)
Expression of Human Anti-Tetanus Toxoid Antibody in Transfected Murine Myeloma Cells (1989) (43)
Do natural killer cells regulate B-cell activity? (1984) (42)
Lymphocyte subsets and macrophages in the male genital tract in health and disease. A monoclonal antibody-based study. (1988) (42)
IL-6, DHEA and the ageing process (1997) (41)
Human seminal plasma is a potent inhibitor of natural killer cell activity in vitro. (1985) (41)
The effect of seminal plasma on macrophage function--a possible contributory factor in sexually transmitted disease. (1983) (41)
The Production and Characterisation of a Panel of Ten Murine Monoclonal Antibodies to Human Procoagulant Factor VIII (1986) (41)
Identifying leucocytes and leucocyte subpopulations in semen using monoclonal antibody probes. (1986) (40)
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. (1967) (40)
Possible role for C-reactive protein in the human natural killer cell response (1983) (40)
Effect of Anti-rat Lymphocyte Antibody on Humoral Antibody Formation (1967) (39)
Cytokine‐modified Mycobacterium smegmatis as a novel anticancer immunotherapy (2004) (38)
Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. (1981) (38)
Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1. (1992) (37)
Relative immunosuppressive activity of human seminal prostaglandins. (1992) (37)
Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells. (1994) (35)
Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro. (1974) (35)
Association of α-Macroglobulins with Lymphoid Cells (1973) (34)
Expression and shedding of ICAM‐1 in bladder cancer and its immunotherapy (1993) (33)
The Effects of Recombinant Human Intereron-Gamma on a Panel of Human Bladder Cancer Cell Lines (1991) (33)
A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator (1987) (32)
Trypsin stabilizers in human serum. The role of α2-Macroglobulin (1966) (32)
The effect of α2-macroglobulin in human serum on trypsin, plasmin, and thrombin activities (1967) (32)
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. (1975) (31)
Immunomodulatory effects of extracellular secretory vesicles isolated from bovine semen. (1995) (31)
Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha. (1992) (31)
The Preparation and Properties of Anti-Lymphocytic Sera1 (1969) (31)
A STUDY OF THE ALPHA-2-MARCROGLOBULIN HOMOLOGUES OF VARIOUS SPECIES. (1965) (29)
A Mouse Monoclonal Antibody with Anti‐A,(B) Specificity Which Agglutinates Ax Cells (1984) (28)
Preliminary studies on the interaction of TNFα and IFNγ with α2-macroglobulin (1992) (27)
Monoclonal antibodies directed against human alpha-thrombin and the thrombin-antithrombin III complex. (1984) (26)
A Two-Site Immunoradiometric Assay for Pth(1–84) Using N and C Terminal Specific Monoclonal Antibodies (1991) (26)
The effect of recombinant cytokines on bladder cancer cells in vitro. (1993) (26)
Effects of C-reactive protein on human lymphocyte responsiveness. (1983) (26)
Immunohistochemical identification of lymphocyte subsets and macrophages in normal human urothelium using monoclonal antibodies. (1986) (25)
Expression of a common secretory granule specific protein as a marker for the extracellular organelles (prostasomes) in human semen. (1994) (25)
Production and use of human monoclonal anti-D antibodies. (1988) (24)
An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. (1992) (23)
Human monoclonal antibodies: their potential, problems, and prospects. (1989) (23)
Synovial cells. A study of the morphology and an examination of protein synthesis of synovial cells. (1966) (22)
The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. (1999) (22)
Quantitative Studies with Antilymphocytic Antibody (1967) (22)
Human monoclonal antibodies and engineered antibodies in the management of cancer. (1990) (22)
Control of leucocyte function-associated antigen-1-dependent cellular conjugation by divalent cations. (1994) (22)
The effect of α2 macroglobulin in commercial cytokine assays (1994) (21)
Prolongation of canine renal allograft survival with antilymphocytic serum. (1968) (21)
Measurement of human and mouse anti-tetanus antibodies and isotype analysis by ELISA. (1986) (21)
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. (1967) (20)
Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region. (1994) (20)
Lymphocyte subsets in renal carcinoma--a sequential study using monoclonal antibodies. (1984) (20)
Preliminary studies on the effect of dehydroepiandrosterone (DHEA) on both constitutive and phytohaemagglutinin (PHA)‐inducible IL‐6 and IL‐2 mRNA expression and cytokine production in human spleen mononuclear cell suspensions in vitro (2001) (19)
B cell responses to HIV and the development of human monoclonal antibodies (1992) (18)
Human Monoclonal Antibody Technology—Are its Achievements, Challenges, and Potential Appreciated? (1989) (18)
A semiquantitative procedure for estimating serum antitrypsin levels. (1966) (18)
Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents. (2001) (17)
Murine monoclonal antibodies against active site epitopes on human endothelial plasminogen activator inhibitor (PAI-1) (1990) (16)
Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice. (1976) (16)
The effects of human seminal plasma and PGE2 on mitogen induced proliferation and cytokine production of human splenic lymphocytes and peripheral blood mononuclear cells. (1996) (16)
The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. (1975) (16)
Anti-lymphocyte serum. (1968) (16)
The Effect of Intravenous and Intramuscular Injection of Corynebacterium parvum (1975) (16)
Organ culture of human lymphoid tissue. I. Characteristics of the system. (1995) (16)
Human monoclonal antibodies — production and potential (1984) (16)
C-reactive protein antigenicity on the surface of human lymphocytes. (1983) (16)
Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for the role of IL-1 alpha. (1994) (16)
Complement: activation, consequences, and control. (1982) (15)
Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine. (1986) (15)
Early post-operative morbidity of total prostatectomy. (1989) (15)
Human atrial natriuretic factor (ANF). Characterisation of a monoclonal antibody panel and its use in radioimmunoassay. (1989) (15)
Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes. (1982) (15)
The use of rat mixed-thymocyte culture-conditioned medium for hybridoma production, cloning and revival. (1987) (15)
Organ culture of human lymphoid tissue. II. Marked differences in cytokine production and proliferation between slice and suspension cultures of human spleen. (1997) (15)
A Monoclonal Antibody-Based Immunoradiometric Assay for h-LH (1984) (14)
The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines. (1991) (14)
Immunopathological effects of intravesical BCG therapy. (1989) (14)
Immunosuppression by seminal plasma from fertile and infertile men: inhibition of natural killer cell function correlates with seminal PG concentration. (1991) (14)
Interactions between cytokines and alpha 2-macroglobulin. (1990) (13)
Production of IL-5, a classical T(H)2 cytokine, following bacillus Calmette guerin immunotherapy of bladder cancer. (1996) (13)
The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapy (2005) (13)
Human seminal plasma suppresses lymphocyte responses in vitro in serum-free medium. (1987) (12)
The Effect of Transplanted Methylcholanthrene Induced Fibrosarcomata and Corynebacterium parvum on the Immune Response of CBA and A/HeJ Mice to Thymus Dependent and Independent Antigens (1974) (12)
Antibody Engineering [and Discussion] (1989) (12)
Stability of Murine Monoclonal Anti‐A, Anti‐B and Anti‐A,B ABO Grouping Reagents and A Multi‐Centre Evaluation of Their Performance in Routine Use 1 (1989) (12)
Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. (1969) (12)
THE DEVELOPMENT AND DISTRIBUTION OF ANTILYMPHOCYTIC AND OTHER ANTIBODIES IN HORSES IMMUNIZED WITH HUMAN LYMPHOID ANTIGENS (1970) (12)
Tonsil Stromal-Cell Lines Expressing FDC-Like Properties: Isolation, Characterization, and Interaction with B Lymphocytes (1998) (12)
The immunosuppressive contribution of prostaglandin components of human semen and their ability to elevate cyclic adenosine monophosphate levels in peripheral blood mononuclear cells. (1994) (11)
Evaluation of lymphocytic responses after treatment with Bacillus Calmette-Guerin and interferon-alpha 2b for superficial bladder cancer. (1999) (11)
The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. (1972) (11)
Commercial production of monoclonal antibodies: A guide for scale-up: Seaver, S.S. (Ed.) 327 pp. Marcel Dekker, New York, 1987. ISBN 0-8247-7765-4 (1988) (11)
The effect of an alpha-globulin preparation and of polyribonuclease complexes on humoral antibody formation. (1968) (11)
Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients afterbacillus Calmette-Guerin immunotherapy (1995) (10)
Studies on the immunosuppressive effect of seminal plasma. (1987) (10)
THE EFFECT OF ANTILYMPHOCYTIC ANTIBODY ON THE PRIMARY IMMUNE RESPONSE OF MICE TO SHEEP ERYTHROCYTES, BOVINE SERUM ALBUMIN, AND TYPE III PNEUMOCOCCUS POLYSACCHARIDE (1971) (10)
Enhancement of Factor VIII-von Willebrand Factor Ristocetin Cofactor Activity by Monoclonal Antibodies (1985) (10)
Soluble urinary CD14 after intravesical bacille Calmette-Guérin immunotherapy for carcinoma in situ. (1997) (10)
Differential production of gamma delta T cells in the urine of bladder cancer patients receiving Bacillus Calmette Guerin immunotherapy. (1997) (10)
Elimination of Normal Horse IgG labelled with Iodine-131 in Rats receiving Horse Anti-rat Lymphocytic IgG (1967) (9)
The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders. (1975) (9)
The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. II. The response to sheep erythrocytes. (1973) (9)
The characterization of a panel of monoclonal antibodies to human coagulation factor IX. (1985) (9)
Further studies on the effect of anti-lymphocytic antibody on humoral antibody formation. (1968) (9)
The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. IV. Variable effect of individual ALG preparations on the immune response to type 3 polysaccharide antigen. (1974) (8)
A comparison of the performance in vitro of precision cut tissue slices and suspensions of human spleen with special reference to immunoglobulin and cytokine production. (1996) (8)
Effect of Acid Treatment on the Immunosuppressive Properties of Anti-lymphocytic IgG (1968) (8)
The response of mice to type III pneumococcal polysaccharide: failure to detect thymus-derived suppressor cells. (1975) (8)
Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat. (1968) (8)
Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines. (1995) (8)
Cell surface phenotype, cytokines, and antibody gene expression in immortalized human B cell lines. (1990) (8)
Cimetidine and therapy of rodent tumours. (1982) (7)
Effect of Anti-rat Lymphocyte Antibody on Humoral Antibody Formation (1967) (7)
A monoclonal antibody to human blood group B. Performance, evaluation and optimisation. (1984) (7)
The effect of anti-alpha2-macroglobulin on K-cell cytolysis and T- and B-cell rosette formation. (1975) (7)
Effect of F(ab′)2 from Rabbit Anti-mouse Lymphocyte IgG on the Graft versus Host Reaction in F1 Hybrid Mice (1968) (7)
The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide. (1973) (7)
The suppression of experimental thyroiditis in the rat by heterologous anti-lymphocyte globulin. (1968) (7)
The production and evaluation of two human monoclonal anti‐D antibodies (1993) (7)
Immunosuppression by seminal plasma and its possible biological significance. (1990) (7)
Human Monoclonal Antibody Technology (1994) (7)
The effect of human alpha 2-macroglobulin on the restoration of humoral responsiveness in x-irradiated mice. (1975) (6)
Antitumour responses induced by short-term pretreatment with tumour cells. (1978) (6)
The preparation and properties of anti-lymphocytic sera. (1969) (6)
Association of host immunoglobulins with solid tumours in vivo. (1979) (6)
Monoclonal Antibodies, Their Production and Potential in Clinical Practice (1984) (6)
The effect of alpha 2 macroglobulin in commercial cytokine assays. (1994) (6)
Antiproliferative effect of IL-6 on transitional cell carcinoma of the bladder. Insight into mechanisms of bacillus Calmette-Guerin immunotherapy. (1997) (5)
Expression of interferon-γ receptors on bladder cancer cells: does it correlate with biological response? (2004) (5)
Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice. (1982) (5)
The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. (1969) (5)
The use of tissue slices in immunological investigations. (1997) (5)
Experiences in the production of human monoclonal antibodies to tetanus toxoid. (1984) (5)
The effect of alpha-2-macroglobulin in human serum on trypsin, plasmin, and thrombin activities. (1967) (4)
Pitfalls in the use of ELISA to screen for monoclonal antibodies raised against small peptides. (1993) (4)
Isotype responses of mice to tetanus-toxoid preparations. (1986) (4)
Preliminary studies on the interaction of TNF alpha and IFN gamma with alpha 2-macroglobulin. (1992) (4)
Are gamma delta T lymphocytes involved in intravesical bacillus Calmette-Guerin immunotherapy of bladder cancer? (1997) (4)
Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice. (1974) (4)
Bladder cancer cells do not express co-stimulatory molecules B7-1, B7-2 and B7-3. (1996) (4)
Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells. (1979) (4)
The effect of anti-lymphocytic antibody on the development of experimental thyroiditis in rats induced by the intra-lymph node injection of rat thyroglobulin in Freund's complete adjuvant. (1971) (4)
The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin. (1971) (4)
Diagnostic paraprotein in papular mucinosis. (1968) (4)
Evaluation of monoclonal antibodies to blood group A. (1984) (4)
Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase. (1986) (4)
Purification and characterisation of soluble intercellular adhesion molecule-1 (sICAM-1) and its effect on cell-mediated cytolysis of tumour cells. (1997) (3)
In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. (1967) (3)
The effect of anti-lymphocytic IgG on unsensitized and sensitized spleen cells in vivo and in vitro. (1969) (3)
The Effects of Seminal Plasma Prostaglandins on T Cells and NK Cells (1993) (3)
Effect of antilymphocyte antibody on humoral antibody formation. (1970) (3)
Trypsin stabilizers in human serum. The role of alpha-2-macroglobulin. (1966) (3)
The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. V. Effects on the class and subclass of antibody produced, and the antibody responses of congenitally athymic mice. (1974) (3)
Monoclonal antibodies to human T lymphocyte surface antigens: Their potential application to urology (2004) (3)
In vivo and in vitro Effect of Anti-lymphocytic IgG on Sensitized Spleen Cells (1968) (3)
Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus. (1992) (3)
Effects of allogenic lymphocytes on induction of tolerance in antilymphocyte globulin-treated x-irradiated rats. (1970) (3)
Testing of monoclonal antibody specificity. (1983) (3)
A two-site immunometric assay for arginine vasopressin. (1990) (2)
A simple method for isolating a2 macroglobulin-cytokine complexes (1994) (2)
Tonsil stromal cell lines expressing follicular dendritic cell-like properties--isolation, characterization and interaction with B lymphocytes. (1997) (2)
Strain Variations in the Primary Humoral Response of Rats and its Susceptibility to Inhibition by Anti-lymphocytic Antibody (1969) (2)
Serological changes in adjuvant-treated mice, their specificity and relevance to tumor immunity (1977) (2)
The papain digestion of human serum α2-macroglobulin (1965) (2)
Monoclonal antibodies to human hypoglossal nucleus which stain neurons and astrocytes in normal brains and brains from cases of Alzheimer-type dementia (1986) (2)
Electron Microscopy in Human Medicine, Vol. 6, Nervous System, Sensory Organs and Respiratory Tract (1981) (2)
Effect of transplanted syngeneic myelomas on the antibody response of mice. (1975) (2)
Immunological and biochemical characteristics of acid citrate eluates from tumour cells: a major non-immunoglobulin component. (1981) (2)
Tumor-associated immunoglobulins, antitumor antibodies, and antiviral antibodies in C. parvum-treated normal and tumor-bearing mice (1978) (2)
Human coagulation factor IX: direct depletion and recovery from plasma, using immobilised monoclonal antibody. (1988) (2)
A monoclonal antibody which prevents reductions in assayed fibrinogen and alpha 2 antiplasmin in plasma samples containing therapeutic concentrations of tissue plasminogen activator (t-PA). (1986) (2)
Serological changes associated with C. parvum treatment in nude mice. (1977) (2)
A Modified Radio‐Immune Antiglobulin Test for the Screening of Anti‐Red Blood Cell Antibodies in Hybridoma Supernatants (1982) (2)
The effect of anaesthesia and surgery for benign disease of the upper urinary tract on circulating leucocyte subpopulations identified with monoclonal antibodies (2004) (2)
Purification and characterisation of soluble intercellular adhesion molecule-1 and its effect on cell-mediated cytolysis of bladder tumour cells. (1997) (2)
The preparation, characterization and application of monoclonal antibodies to human prostatic acid phosphatase (PAP). (1984) (2)
Effect of Adjuvants on the Immunosuppressive Properties of Antilymphocytic Globulin (1970) (1)
Characterization of certain minor monodispersed bands found on serum protein electrophoresis as C-reactive protein. (1983) (1)
Is the success of BCG tumour immunotherapy due to the induction of co-stimulatory molecules? (1997) (1)
Cancer vaccines and immunotherapy: Immunotherapy of bladder cancer (2000) (1)
Further studies on the serological effects of C. parvum immunotherapy in cancer patients. (1977) (1)
The loss of the immunosuppressive properties of anti-lymphocytic globulin following absorption with immunizing antigen (sheep erythrocytes). (1971) (1)
Immune Responses: Primary and Secondary (2002) (1)
Studies on the association of alpha2-macroglobulin with T, B and K cells. (1975) (1)
Human immunodeficiency virus: strategies for protection and therapy. (1988) (1)
Tumour-associated immunoglobulins and host cell infiltration (1981) (1)
The characterisation of tumour associated immunoglobulins (Ig) (1980) (1)
Effect of acid treatment on the immunosuppressive properties of antilymphocytic IgG (1968) (1)
Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report. (1989) (1)
Association of alpha-macroglobulins with lymphoid cells. (1973) (1)
The automated production by immunoaffinity chromatography of the human pituitary glycoprotein hormones thyrotropin, follitropin and lutropin (2007) (1)
Engineering recombinant mycobacteria to secrete cytokines (1997) (0)
A simple method for isolating alpha 2 macroglobulin-cytokine complexes. (1994) (0)
Antilymphocyte serum. (1968) (0)
Expression of B7-1, -2, -3 and CD40 costimulatory molecules on bladder and pancreatic carcinoma cell lines (1997) (0)
Antibodies to tumour eluates react preferentially with non-lymphoid tumours (2004) (0)
Seruma2-macroglobulin levels indiabetes (1980) (0)
Synthesis of Synovial Cells Examination of Protein the Morphology and an Synovial Cells : A Study of (2008) (0)
THE PAPAIN DIGESTION OF HUMAN SERUM ALPHA-2-MACROGLOBULIN. (1965) (0)
Synovial Cells: A Study of the Morphology and an Examination of Protein Synthesis of Synovial Cells (1966) (0)
Letters to the EditorANTILYMPHOCYTE SERUM (1968) (0)
The Characterization of Anti-lymphocytic Antibodies (1969) (0)
The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions. (1973) (0)
Electrophoresis—A practical laboratory manual (1967) (0)
Antilymphocytic serum--its constitution, effect and mode of action. (1970) (0)
Fluoresceinated α2-macroglobulin as a probe for studying macrophages (1985) (0)
Mycobacterial regulation of ICAM-1 on human cancers (1997) (0)
The effect of human splenic stromal cells on terminal differentiation of activated B lymphocytes (1997) (0)
The effect of purified soluble intercellular adhesion molecule-1 (sICAM-1) on LAK cell-mediated cytolysis (1997) (0)
Studies on anti-lymphocytic antibodies and other proteins (1969) (0)
71 Monoclonal antibodies used to distinguish between different forms of endothelial plasminogen activator inhibitor (PAI-1) (1988) (0)
Antilymphocytic Serum (1970) (0)
EFFECT OF ANTILYMPHOCYTIC ANTIBODY (1967) (0)
The immunosuppressive properties of sub-fractions of antilymphocytic IgG of equine origin. (1971) (0)
Induction ofICAM 1expression on bladder tumoursbyBCG immunotherapy (1994) (0)
Expression of TNFα by recombinant mycobacteria (1997) (0)
THE ROLE OF HEPATOCYTE GROWTH FACTOR AND ITS RECEPTOR C-MET IN INTERACTIONS BETWEEN STROMAL CELLS AND LYMPHOCYTES IN LYMPHOID ORGANS. (1999) (0)
Optimization of assay conditions in monoclonal-based immunoradiometric assay. (1984) (0)
The Target (or Mode of Action) of Antilymphocytic Antibodies (1972) (0)
Studies with anti-lymphocytic antibody and antibody-fragments. (1970) (0)
Studies on the effect of phytohaemagglutinin and anti-lymphocytic globulin on the primary humoral response to sheep erythrocytes and bovine serum albumin in hooded and Wistar rats. (1970) (0)
Antibody responses, antitumour antibodies and Ig class and subclass levels in C. parvum treated mice. (1977) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Keith James?

Keith James is affiliated with the following schools:

University of Edinburgh

Keith James's Academic­Influence.com Rankings

Keith James's Degrees

Similar Degrees You Can Earn

Why Is Keith James Influential?

Keith James's Published Works

Published Works

What Schools Are Affiliated With Keith James?

Keith James's AcademicInfluence.com Rankings